Supplementary Figure S4 from Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance

2026 Open access

Read full text
Authors: David Bakhshinyan, Stefan Custers, Laura Escudero, Yujin Suk, Kevin R. Brown, Hardikkumar M. Patel, Ashley Adile, Chirayu Chokshi, Muhammad Vaseem Shaikh, Dillon McKenna, Maleeha A. Qazi, Kui Zhai
+6 more David D. Tieu, Katherine Chan, Marla L. Weetall, Chitra Venugopal, Jason Moffat, Sheila Uttam Singh
DOI: 10.1158/1078-0432.31006783
Cited by: 0

Abstract

Supplemental Figure 4: Assays evaluating the suitability of SU_MB002 for the in vitro genome-wide CRISPR-Cas9 screen

Fields of Study & Subjects

Glioma Diagnosis and Treatment CRISPR and Genetic Engineering PARP inhibition in cancer therapy

Publication details

Publication date
6 January 2026